# Pyxis Oncology, Inc.: Form SC 13D/A, filed Apr 3, 2024

- Company: [Pyxis Oncology, Inc.](/companies/pyxs.md) (CIK 1782223)
- Form: SC 13D/A
- Filed: 2024-04-03
- Accepted by EDGAR: Apr 3, 2024, 17:10 ET
- Period: not reported
- Accession: 0000950170-24-041264
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1782223/000095017024041264/2024_schedule_13da_-_lar.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1782223/000095017024041264/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1782223/000095017024041264/2024_schedule_13da_-_lar.htm

Filed Apr 3, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-041264. Last ingested by Listed: Nov 3, 2026, 10:04 ET. No prices; not investment advice.